Morgan Stanley raised the firm’s price target on ArcBest (ARCB) to $150 from $120 and keeps an Overweight rating on the shares. Q2 guidance was modestly above expectations and management endorsed improving conditions, the analyst tells investors in a post-earnings note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARCB:
- ArcBest price target raised to $134 from $116 at Stifel
- Thomas Wadewitz Maintains Hold on Balanced Risk/Reward, Raises Price Target to $122 on Improved Earnings Outlook
- ArcBest price target raised to $122 from $98 at UBS
- ArcBest price target raised to $150 from $122 at Citi
- Arcbest Earnings Call: Growth Resilient, Margins Squeezed